Hormone replacement therapy (hrt) and subclinical cardiovascular disease as assessed by cardiovascular magnetic resonance (cmr) imaging: insights from uk biobank.

26 May 2017 (13:55 - 14:05)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Mihir Sanghvi

Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail

Evaluation of cardiac risk using dobutamine cardiac stress magnetic resonance prior to renal transplantation; a 3.3 year follow up

Doctor U. Sheikh (Torbay, GB)

Presentation thumbnail

Impact of high-flow oxygen on perfusion, microvascular and capillary function in normal volunteers and patients with coronary artery disease: a cardiovascular magnetic resonance and invasive coronary physiology study.

Doctor D. Ripley (Newcastle-Upon-Tyne, GB)

Presentation thumbnail

Prognostic significance of remote myocardium alterations assessed by quantitative non-contrast t1 mapping in st-elevation myocardial infarction

Doctor S. Reinstadler (Innsbruck, AT)

Presentation thumbnail

Association of acute kidney injury with myocardial damage in patients with reperfused st-elevation myocardial infarction

Doctor M. Reindl (Innsbruck, AT)

Presentation thumbnail

Automated in-line myocardial perfusion mapping - validation against angiography in suspected coronary artery disease

Doctor K. Knott (London, GB)

Access the full session

Session thumbnail

Oral abstract session 1

The Event

EuroCMR 2017

26 May 2017 13:55 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources